Moderna, Inc.: Working Hard But Competition Is Working Harder
MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
New Jersey Business22h
BioNJ Elects Board Officers and Trustees
Life sciences trade association BioNJ has announced the election of its 2025 Officers and Board Members in concert with BioNJ ...